| Dr Julianne Martins Parente-heck, MD | |
|
7350 Futures Dr Ste 17, Orlando, FL 32819 | |
| (321) 214-0028 | |
| (407) 429-3833 |
| Full Name | Dr Julianne Martins Parente-heck |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 16 Years |
| Location | 7350 Futures Dr Ste 17, Orlando, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053635482 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | ME115446 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Florida Kidney Center - Osceola | Orlando, FL | Dialysis facility |
| Orlando Health | Orlando, FL | Hospital |
| Adventhealth Orlando | Orlando, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Nephrology Plc | 3971772062 | 4 |
News Archive
Despite the conventional belief that for women giving birth "once a cesarean always a cesarean," vaginal delivery after cesarean - also known as "trial of labor after cesarean delivery" - offers a safe option for many second-time mothers with no contraindications.
The six-month results from the prospective, multicenter, single-arm 4EVER study demonstrate efficacy and safety of BIOTRONIK's Pulsar Stent System in 120 superficial femoral artery (SFA) patients. Analysis of the 120 patients showed excellent device performance, very promising patency rates and convincing evidence of the benefits of lower limb intervention on a 4F platform. Although only the interim results were presented at the Leipzig Interventional Course (LINC 2012) in Leipzig, Germany, analysis of the full cohort has recently been made available.
Neuroscientists at Tufts University School of Medicine have discovered a new signaling pathway that directly connects two major receptors in the brain associated with learning and memory – the N-methyl-D-aspartate receptor (NMDAR) and the alpha 7 nicotinic acetylcholine receptor (a7nAChR) – which has significance for current efforts to develop drugs to treat schizophrenia.
The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.
› Verified 6 days ago
| Entity Name | Florida Nephrology Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265747828 PECOS PAC ID: 3971772062 Enrollment ID: O20110805000550 |
News Archive
Despite the conventional belief that for women giving birth "once a cesarean always a cesarean," vaginal delivery after cesarean - also known as "trial of labor after cesarean delivery" - offers a safe option for many second-time mothers with no contraindications.
The six-month results from the prospective, multicenter, single-arm 4EVER study demonstrate efficacy and safety of BIOTRONIK's Pulsar Stent System in 120 superficial femoral artery (SFA) patients. Analysis of the 120 patients showed excellent device performance, very promising patency rates and convincing evidence of the benefits of lower limb intervention on a 4F platform. Although only the interim results were presented at the Leipzig Interventional Course (LINC 2012) in Leipzig, Germany, analysis of the full cohort has recently been made available.
Neuroscientists at Tufts University School of Medicine have discovered a new signaling pathway that directly connects two major receptors in the brain associated with learning and memory – the N-methyl-D-aspartate receptor (NMDAR) and the alpha 7 nicotinic acetylcholine receptor (a7nAChR) – which has significance for current efforts to develop drugs to treat schizophrenia.
The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Julianne Martins Parente-heck, MD 7350 Futures Dr Ste 17, Orlando, FL 32819 Ph: (321) 214-0028 | Dr Julianne Martins Parente-heck, MD 7350 Futures Dr Ste 17, Orlando, FL 32819 Ph: (321) 214-0028 |
News Archive
Despite the conventional belief that for women giving birth "once a cesarean always a cesarean," vaginal delivery after cesarean - also known as "trial of labor after cesarean delivery" - offers a safe option for many second-time mothers with no contraindications.
The six-month results from the prospective, multicenter, single-arm 4EVER study demonstrate efficacy and safety of BIOTRONIK's Pulsar Stent System in 120 superficial femoral artery (SFA) patients. Analysis of the 120 patients showed excellent device performance, very promising patency rates and convincing evidence of the benefits of lower limb intervention on a 4F platform. Although only the interim results were presented at the Leipzig Interventional Course (LINC 2012) in Leipzig, Germany, analysis of the full cohort has recently been made available.
Neuroscientists at Tufts University School of Medicine have discovered a new signaling pathway that directly connects two major receptors in the brain associated with learning and memory – the N-methyl-D-aspartate receptor (NMDAR) and the alpha 7 nicotinic acetylcholine receptor (a7nAChR) – which has significance for current efforts to develop drugs to treat schizophrenia.
The Substance Abuse and Mental Health Services Administration (SAMHSA) today announced $13 million in new grants to help state and local courts offer treatment and recovery support instead of incarceration for individuals who are in a court system due to mental health or substance use disorders.
› Verified 6 days ago
Vamsi Kiran Kodumuri, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 258 S Chickasaw Trl Ste 203, Orlando, FL 32825 Phone: 407-303-6588 | |
Francoeur Cadet, D.O Nephrology Medicare: Medicare Enrolled Practice Location: 232 N Orange Blossom Trl, Orlando, FL 32805 Phone: 407-428-5751 Fax: 407-447-7245 | |
Andrija Vidic, D.O Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2415 N Orange Ave Ste 700, Orlando, FL 32804 Phone: 407-303-2474 Fax: 407-303-0680 | |
Azin Azarfar, MD Nephrology Medicare: Medicare Enrolled Practice Location: 3400 Quadrangle Blvd, Orlando, FL 32817 Phone: 407-266-3627 Fax: 407-266-4911 | |
Zain Zamir, MD Nephrology Medicare: Medicare Enrolled Practice Location: 2501 N Orange Ave Ste 235, Orlando, FL 32804 Phone: 407-303-7169 | |
Dr. Arsenio R Rodriguez, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1745 N Mills Avenue, Orlando, FL 32803 Phone: 407-841-7151 Fax: 407-648-2259 | |
Dr. Maria R Flores, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 70 W Gore St, Suite 100, Orlando, FL 32806 Phone: 407-426-8484 Fax: 404-426-8575 |